Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02302170Phase 3Completed
A Phase 3 trial of oral recombinant Helicobacter pylori vaccine in Helicobacter pylori infection, sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started Dec 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02302170.